WO2007086397A1 - Fat composition for ameliorating lipid metabolism - Google Patents

Fat composition for ameliorating lipid metabolism Download PDF

Info

Publication number
WO2007086397A1
WO2007086397A1 PCT/JP2007/051043 JP2007051043W WO2007086397A1 WO 2007086397 A1 WO2007086397 A1 WO 2007086397A1 JP 2007051043 W JP2007051043 W JP 2007051043W WO 2007086397 A1 WO2007086397 A1 WO 2007086397A1
Authority
WO
WIPO (PCT)
Prior art keywords
oil
composition
group
fat
palm kernel
Prior art date
Application number
PCT/JP2007/051043
Other languages
French (fr)
Japanese (ja)
Inventor
Nobuo Sagi
Nobuhiko Tachibana
Haruyasu Kida
Kiyoharu Takamatsu
Original Assignee
Fuji Oil Company, Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Oil Company, Limited filed Critical Fuji Oil Company, Limited
Priority to JP2007555962A priority Critical patent/JPWO2007086397A1/en
Publication of WO2007086397A1 publication Critical patent/WO2007086397A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B7/00Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils
    • C11B7/0075Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of melting or solidifying points
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings, cooking oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to an oil and fat composition for improving lipid metabolism.
  • Patent Documents 1 to 4 disclose an oil and fat composition containing diglyceride as an active ingredient and having little body fat accumulation, but the safety of using an oil and fat composition rich in diglyceride as an edible food is completely It is not proved to be.
  • Patent Document 1 Japanese Patent Laid-Open No. 4 300826
  • Patent Document 2 JP-A-8-60180
  • Patent Document 3 Japanese Patent Laid-Open No. 10-176181
  • Patent Document 4 Japanese Unexamined Patent Publication No. 2000-309794
  • An object of the present invention is to suppress body weight gain and body fat accumulation with improved safety, and An object of the present invention is to provide an oil and fat composition for improving lipid metabolism having a function of reducing neutral lipids in blood and liver lipids.
  • the present invention relates to
  • composition of fatty acids is SZU 0.6 to 2.5, C12ZU is 0.4 to 1.5, and the composition of triglycerides is a total of 32 to 36 carbon atoms in the asil group.
  • An oil / fat composition for improving lipid metabolism comprising a triglyceride containing less than 30% of a triglyceride and a triglyceride having a total power of 2 to 48 carbon atoms of an acyl group in an amount of 35% or more.
  • S total saturated fatty acid content in weight percent as methyl ester
  • U total unsaturated fatty acid content in weight percent as methyl ester.
  • SZU is 0.6 to 2.5
  • C12ZU is 0.5
  • the triglyceride composition is 4 to 1.5 and the total triglyceride composition has 32 to 36 carbon atoms in the acyl group is less than 30% of the total, and the total carbon power of the acyl group is 2 to 48.
  • An oil / fat composition for improving lipid metabolism containing at least 35% of a triglyceride is used to suppress weight gain and body fat accumulation, as well as neutral fat in blood and liver lipids. Quality can be reduced.
  • the fat and oil composition for improving lipid metabolism of the present invention can be widely used for foods usually containing fats and oils.
  • liquid coffee cream typified by porcelain cream 'margarine' mayonnaise 'dressing' used as emulsified foods such as dairy products, ice cream confections, chocolate confectionery, breads, spray fats and oils
  • processed meat products such as ham 'sausage'
  • seafood processed foods such as power maboko 'chikuwa', etc. without sacrificing flavor and texture.
  • the fat and oil composition for improving lipid metabolism of the present invention has an effect of suppressing weight gain and body fat accumulation, and reducing neutral lipids in blood and liver lipids.
  • the oil and fat composition of the present invention has a composition of triglyceride having SZU of 0.6 to 2.5 and C12 / U of 0.4 to 1.5 in the composition of fatty acids constituting the oil and fat composition of the present invention.
  • the total number of triglycerides in which the total number of carbon atoms in the acyl group is 32 to 36 is less than 30%, and the total amount of triglycerides in which the total number of carbon atoms in the acyl group is 2 to 48 is 35% or more. is required.
  • the oil and fat composition of the present invention can be obtained by fractionating palm kernel oil.
  • the separation method is not limited to wet or dry separation, but dry separation without using a solvent or the like can be produced safely.
  • the composition of the fatty acid and the triglyceride to be constituted can be easily within the range necessary for the oil and fat composition of the present invention.
  • the oil and fat composition of the present invention can be used as it is, the oil and fat composition of the present invention may be partially solidified at low temperatures, so depending on the application, it may be appropriately blended with liquid oil or the like. You can use it.
  • Palm kernel olein was separated into liquid fraction (IV35.1, yield 41.7%) and crystal fraction (IV15.1, yield 58.3%) by dry fractionation.
  • the liquid fraction palm kernel double olein was obtained as the low melting point fraction of palm kernel oil.
  • Medium chain fatty acid triglyceride MCT (Coconard MT—N, manufactured by Kao Corporation) and refined rapeseed oil are mixed at 1: 3: 87 (weight ratio), and random transesterification of this mixed oil is performed according to a conventional method.
  • These palm kernel olein, palm kernel double olein, palm olein, palm kernel double olein random transesterified oil and fat, and the random transesterified oil obtained in Production Example 4 were purified by a conventional method.
  • Their fatty acid composition and triglyceride composition are shown in Tables 1 and 2.
  • SZU of palm kernel olein, palm kernel double olein, palm olein, palm kernel double olein random transesterified oil and fat and the random transesterified oil obtained in Production Example 4 are 3.42, 1.99 and 6. 75, 1.99 and 0.25, and C12ZU was 1.96, 1.04, 3.41, 1.04 and 0, respectively.
  • C32 to 36 of palm kernel olein, palm kernel double olein, palm olein, palm kernel double olein random transesterified oil and the random transesterified oil obtained in Production Example 4 are 37.7% and 26.
  • C42 to 48 are 30.4%, 40.6%, 14.4%, 47.7%, and 36.7%, respectively. It was. However, C32-36: Triglyceride in which the total carbon number of the acyl group is 32 to 36, C 42-48: Triglyceride in which the total carbon number of the acyl group is 42 to 48.
  • Butyl esters were prepared by reaction of each oil sample with n-butanol using a sulfuric acid catalyst and analyzed under the following glc conditions. The obtained chromatogram data (% by weight as a ptyl ester) was expressed in terms of weight% as a methyl ester in terms of molecular weight.
  • Capillary column Frontier Lab UA15W 0.15F (0.5 mml. D. 15m) Column temperature: 220 ° C to 12 ° C / min up to 350 ° C
  • mice Digestion and absorption tests were conducted in mice for 8 weeks using each refined oil of palm kernel olein, palm kernel double olein, palm olein and palm kernel double olein random transesterified oil obtained in Production Examples 1 to 3. It was.
  • the mouse used was C57BLZ6J. After pre-breeding from 7 weeks of age to 1 week, 8 mice in each group were controlled with the soybean oil group in the mixed feed diet composition shown in Table 3 with a partial improvement in the AIN-93G composition. Breeding for weeks, body weight change 'feed efficiency • Body fat percentage was measured. The body fat percentage was measured using a PIXImus2 (GE Medical Systems), an X-ray bone density measuring device dedicated to experimental mice.
  • PIXImus2 GE Medical Systems
  • Table 4 shows the results of a 56-day digestion and absorption test in mice.
  • palm kernel double olein about 12% suppression of body weight gain was observed compared to the soybean oil group as a control, and about 17% suppression was observed in body fat percentage, which was caused by excessive intake of fat. It was suggested that palm kernel double olein is effective as an anti-obesity oil.
  • the oil / fat composition that has shown all of these effects of reducing body weight gain, body fat accumulation, blood neutral lipid and liver neutral lipid, etc. It is only when it has.
  • Table 14 shows the results of a 140-day high-fat diet long-term feeding test in mice. In the group using palm kernel double violet, about 4.2% reduction in body weight was observed compared to the soybean oil group as a control.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Edible Oils And Fats (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fats And Perfumes (AREA)

Abstract

A fat composition for lipid metabolism amelioration which has improved safety and has the functions of inhibiting weight increase, inhibiting body fat accumulation, and reducing natural lipids in the blood and liver lipids. The fat composition for lipid metabolism amelioration has a composition of constituent fatty acids in which S/U is 0.6-2.5 and C12/U is 0.4-1.5 and a composition of constituent triglycerides in which the triglycerides in which the total number of carbon atoms in the acyl groups is 32-36 account for less than 30% of all the triglycerides and the triglycerides in which the total number of carbon atoms in the acyl groups is 42-48 account for 35% or more of all the triglycerides.

Description

明 細 書  Specification
脂質代謝改善用油脂組成物  Oil composition for improving lipid metabolism
技術分野  Technical field
[0001] 本発明は、脂質代謝改善用油脂組成物に関するものである。  [0001] The present invention relates to an oil and fat composition for improving lipid metabolism.
背景技術  Background art
[0002] 近年食生活の欧米化に伴って、日本の食生活においては脂質摂取量が増加し、摂 取エネルギーにおける脂質のシェアは 50年前の 3倍に達している。このことは肥満や 、血中トリグリセリド(中性脂肪)値および血中コレステロール値の増加に由来する生 活習慣病である高脂血症,糖尿病および高血圧と密接に関与しており,心疾患およ び脳血管疾患を誘発すると考えられている。動脈硬化と密接に関係しているため、こ れらの値を低く保つことは生活習慣病予防の面力 特に大切であり、肥満予防には 食事の量だけではなぐ質の重要性が大切であると報告されている。しかし、油脂は 食品の呈味に不可欠であり、し力も油脂は熱媒体としての調理上の機能もあり、摂取 量を単純に減らすのは簡単ではな ヽと 、う問題があった。  [0002] In recent years, with the Westernization of dietary habits, lipid intake has increased in Japanese diets, and the share of lipids in intake energy has tripled 50 years ago. This is closely related to obesity and hyperlipidemia, diabetes and hypertension, which are lifestyle-related diseases derived from increased blood triglyceride (triglyceride) and blood cholesterol levels. And is thought to induce cerebrovascular disease. Since these are closely related to arteriosclerosis, keeping these values low is particularly important for preventing lifestyle-related diseases, and for obesity prevention, the importance of quality not only by the amount of food is important. It has been reported. However, fats and oils are indispensable for the taste of food, and strength and fats also have a cooking function as a heat medium, so it is difficult to simply reduce the intake.
[0003] そのためこの改善策として、脂質代謝改善を目的とした様々な機能性食品 ·素材の 開発が活発となっている。特許文献 1〜4のような方法が提案され商品化されている 力 いずれも天然の油脂とは言いがたいという欠点を有している。特に、特許文献 1 〜3にはジグリセリドを有効成分とする体脂肪蓄積が少ない油脂組成物が開示されて いるが、ジグリセリドを豊富に含む油脂組成物を食用として用いることへの安全性は、 完全に証明されて 、るわけではな 、。  [0003] For this reason, development of various functional foods / materials aimed at improving lipid metabolism has become active. The powers proposed and commercialized as described in Patent Documents 1 to 4 all have the disadvantage that it is difficult to say that they are natural fats and oils. In particular, Patent Documents 1 to 3 disclose an oil and fat composition containing diglyceride as an active ingredient and having little body fat accumulation, but the safety of using an oil and fat composition rich in diglyceride as an edible food is completely It is not proved to be.
[0004] 特許文献 1 :特開平 4 300826号公報  [0004] Patent Document 1: Japanese Patent Laid-Open No. 4 300826
特許文献 2:特開平 8— 60180号公報  Patent Document 2: JP-A-8-60180
特許文献 3 :特開平 10— 176181号公報  Patent Document 3: Japanese Patent Laid-Open No. 10-176181
特許文献 4:特開 2000 - 309794号公報  Patent Document 4: Japanese Unexamined Patent Publication No. 2000-309794
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0005] 本発明の目的は、安全性の向上した体重増加抑制および体脂肪蓄積抑制ならびに 血中および肝臓脂質中の中性脂質低減機能を有する脂質代謝改善用油脂組成物 を提供することにある。 [0005] An object of the present invention is to suppress body weight gain and body fat accumulation with improved safety, and An object of the present invention is to provide an oil and fat composition for improving lipid metabolism having a function of reducing neutral lipids in blood and liver lipids.
課題を解決するための手段  Means for solving the problem
[0006] 本発明者等は上記の問題を解決するため鋭意研究の結果、意外にもラウリン酸を主 とする飽和脂肪酸とォレイン酸を主とする長鎖一価不飽和脂肪酸の比率が特定の範 囲内にあり、かつ特定のトリグリセリドの糸且成を有する油脂糸且成物が体重増加抑制お よび体脂肪蓄積抑制ならびに血中および肝臓脂質中の中性脂質低減機能を有する ことを見出し、本発明を完成するに至った。  [0006] As a result of diligent research to solve the above problems, the present inventors have unexpectedly found that the ratio of saturated fatty acid mainly composed of lauric acid to long-chain monounsaturated fatty acid mainly composed of oleic acid is specified. It was found that an oil thread and a composition having a specific triglyceride thread within the range has a function of suppressing weight gain and body fat accumulation and a function of reducing neutral lipids in blood and liver lipids. The invention has been completed.
[0007] すなわち本発明は、  That is, the present invention relates to
(1)構成する脂肪酸の組成において SZUが 0. 6〜2. 5、C12ZUが 0. 4〜1. 5で あり、かつ構成するトリグリセリドの組成においてァシル基の炭素数合計が 32〜36個 であるトリグリセリドが全体の 30%未満、ァシル基の炭素数合計力 2〜48個であるト リグリセリドを全体の 35%以上含有する脂質代謝改善用油脂組成物。ただし S:メチ ルエステルとしての重量%で表した飽和脂肪酸含量の合計、 U:メチルエステルとし ての重量%で表した不飽和脂肪酸含量の合計。  (1) The composition of fatty acids is SZU 0.6 to 2.5, C12ZU is 0.4 to 1.5, and the composition of triglycerides is a total of 32 to 36 carbon atoms in the asil group. An oil / fat composition for improving lipid metabolism, comprising a triglyceride containing less than 30% of a triglyceride and a triglyceride having a total power of 2 to 48 carbon atoms of an acyl group in an amount of 35% or more. Where S: total saturated fatty acid content in weight percent as methyl ester, U: total unsaturated fatty acid content in weight percent as methyl ester.
(2)パーム核油を分別することによって得られる(1)記載の脂質代謝改善用油脂組 成物。  (2) The fat composition for improving lipid metabolism according to (1), obtained by fractionating palm kernel oil.
(3)パーム核油を複数回分別することによって得られる (1)、 (2)記載の脂質代謝改 善用油脂組成物。  (3) The fat and oil composition for improving lipid metabolism according to (1) and (2), which is obtained by fractionating palm kernel oil a plurality of times.
(4)パーム核油を乾式分別することによって得られる (1)、 (2)記載の脂質代謝改善 用油脂組成物。  (4) The oil / fat composition for improving lipid metabolism according to (1) or (2), obtained by dry fractionating palm kernel oil.
である。  It is.
発明の効果  The invention's effect
[0008] 以上のように、構成する脂肪酸の組成において SZUが 0. 6〜2. 5、 C12ZUが 0.  [0008] As described above, in the composition of the constituent fatty acids, SZU is 0.6 to 2.5, C12ZU is 0.5.
4〜1. 5であり、かつ構成するトリグリセリドの組成においてァシル基の炭素数合計が 32〜36個であるトリグリセリドが全体の 30%未満、ァシル基の炭素数合計力 2〜4 8個であるトリグリセリドを全体の 35%以上含有する脂質代謝改善用油脂組成物は、 体重増加抑制および体脂肪蓄積抑制用ならびに血中および肝臓脂質中の中性脂 質を低減させることができる。 The triglyceride composition is 4 to 1.5 and the total triglyceride composition has 32 to 36 carbon atoms in the acyl group is less than 30% of the total, and the total carbon power of the acyl group is 2 to 48. An oil / fat composition for improving lipid metabolism containing at least 35% of a triglyceride is used to suppress weight gain and body fat accumulation, as well as neutral fat in blood and liver lipids. Quality can be reduced.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0009] 本発明の脂質代謝改善用油脂組成物は、通常油脂を含有する食品に広く使用する ことができる。例えばポーシヨンクリームに代表される液体状のコーヒークリーム 'マー ガリン'マヨネーズ 'ドレッシング '乳製品といった乳化食品、アイスクリームのような冷 菓、チョコレートに代表される菓子類、パン類、スプレー油脂として使用してスナック 菓子などに、あるいはハム'ソーセージ等の食肉加工品、力まぼこ'ちくわ等の水産加 工食品などに添加して風味'食感を損なうことなく使用できる。  [0009] The fat and oil composition for improving lipid metabolism of the present invention can be widely used for foods usually containing fats and oils. For example, liquid coffee cream typified by porcelain cream 'margarine' mayonnaise 'dressing' used as emulsified foods such as dairy products, ice cream confections, chocolate confectionery, breads, spray fats and oils It can be added to snacks and confectionery, processed meat products such as ham 'sausage', seafood processed foods such as power maboko 'chikuwa', etc. without sacrificing flavor and texture.
[0010] 本発明の脂質代謝改善用油脂組成物は、体重増加抑制および体脂肪蓄積抑制用 ならびに血中および肝臓脂質中の中性脂質を低減させる効果を有する。  [0010] The fat and oil composition for improving lipid metabolism of the present invention has an effect of suppressing weight gain and body fat accumulation, and reducing neutral lipids in blood and liver lipids.
[0011] 本発明の油脂組成物は、構成する脂肪酸の組成において SZUが 0. 6〜2. 5であり 、かつ C12/Uが 0. 4〜1. 5であり、かつ構成するトリグリセリドの組成においてァシ ル基の炭素数合計が 32〜36個であるトリグリセリドが全体の 30%未満であり、かつ ァシル基の炭素数合計力 2〜48個であるトリグリセリドを全体の 35%以上含有する ことが必要である。  [0011] The oil and fat composition of the present invention has a composition of triglyceride having SZU of 0.6 to 2.5 and C12 / U of 0.4 to 1.5 in the composition of fatty acids constituting the oil and fat composition of the present invention. The total number of triglycerides in which the total number of carbon atoms in the acyl group is 32 to 36 is less than 30%, and the total amount of triglycerides in which the total number of carbon atoms in the acyl group is 2 to 48 is 35% or more. is required.
[0012] 構成する脂肪酸の組成において SZUが 2. 5より大きい場合には、目的とする体重 増加抑制などの著 、効果が得られ難!、。特に体脂肪蓄積抑制の効果が得られな い。また SZUが 0. 6未満の場合には、血液中性脂質低減の効果が全く得られない  [0012] When SZU is larger than 2.5 in the composition of the fatty acid constituting the target, it is difficult to obtain a remarkable effect such as suppression of weight gain. In particular, the effect of suppressing body fat accumulation cannot be obtained. If SZU is less than 0.6, no effect of reducing blood neutral lipid can be obtained.
[0013] C12ZUが 1. 5より大きい場合にも同様に、目的とする体重増加抑制などの著しい 効果が得られ難い。特に体脂肪蓄積抑制の効果が全く得られない。 C12ZUが 0. 4 未満の場合には、血液中性脂質低減の効果が得られな 、。 [0013] Similarly, when C12ZU is greater than 1.5, it is difficult to obtain a remarkable effect such as suppression of weight gain. In particular, no effect of suppressing body fat accumulation can be obtained. When C12ZU is less than 0.4, the effect of reducing blood neutral lipid cannot be obtained.
[0014] 炭素数合計が 32〜36個であるトリグリセリドが全体の 30%以上である場合にも、目 的とする体重増加抑制などの著し 、効果が得られ難 、。特に体脂肪蓄積抑制の効 果が全く得られない。 [0014] Even when triglycerides having a total carbon number of 32 to 36 are 30% or more of the total, significant effects such as suppression of weight gain, etc., are difficult to obtain. In particular, no effect of suppressing body fat accumulation can be obtained.
[0015] 一方、炭素数合計力 2〜48個であるトリグリセリドが全体の 35%未満である場合に も、目的とする体重増加抑制などの著しい効果が得られ難い。特に体脂肪蓄積抑制 の効果が全く得られない。 [0016] 本発明の油脂組成物は、パーム核油を分別することによって得ることが出来る。分別 方法は、湿式、乾式分別等限定はされないが、溶剤等を使用しない乾式分別が安全 に生産することができる。また複数回分別することが構成する脂肪酸および構成する トリグリセリドの組成を容易に本発明の油脂組成物に必要な範囲内にすることが出来 るという点で好ましい。 [0015] On the other hand, even when the triglyceride having a total carbon number of 2 to 48 is less than 35% of the total, it is difficult to obtain a significant effect such as suppression of weight gain. In particular, no effect of suppressing body fat accumulation can be obtained. [0016] The oil and fat composition of the present invention can be obtained by fractionating palm kernel oil. The separation method is not limited to wet or dry separation, but dry separation without using a solvent or the like can be produced safely. In addition, it is preferable that the composition of the fatty acid and the triglyceride to be constituted can be easily within the range necessary for the oil and fat composition of the present invention.
[0017] 本発明の油脂組成物はそのままでも使用可能であるが、本発明の油脂組成物は低 温においては一部固化することもあるため、用途によっては適宜液体油などとプレン ドして使用することちできる。  [0017] Although the oil and fat composition of the present invention can be used as it is, the oil and fat composition of the present invention may be partially solidified at low temperatures, so depending on the application, it may be appropriately blended with liquid oil or the like. You can use it.
実施例  Example
[0018] 以下に本発明の実施例を示し本発明をより詳細に説明する力 本発明の精神は以 下の実施例に限定されるものではない。なお、例中、%及び部は、いずれも重量基 準を意味する。  [0018] The power of the present invention will be described in more detail below with reference to examples of the present invention. The spirit of the present invention is not limited to the following examples. In the examples, “%” and “part” mean weight standards.
[0019] 製造例 1  [0019] Production Example 1
IV (沃素価) 23. 4のパーム核ォレインを乾式分別により液体画分 (IV35. 1、収率 4 1. 7%)と結晶画分 (IV15. 1、収率 58. 3%)に分画し、パーム核油の低融点画分と して液体画分( パーム核ダブルォレイン)を得た。  IV (iodine value) 23.4 Palm kernel olein was separated into liquid fraction (IV35.1, yield 41.7%) and crystal fraction (IV15.1, yield 58.3%) by dry fractionation. The liquid fraction (palm kernel double olein) was obtained as the low melting point fraction of palm kernel oil.
[0020] 製造例 2 [0020] Production Example 2
IV 8. 1の椰子油 1部をアセトン 4部に溶解させた後、 4°Cまで冷却し結晶析出さ せ 30分保持してカゝら減圧下で濾過により結晶部と濾液部に分別した。濾液部力ゝら脱 溶剤によって椰子油の低融点画分として液体画分 (椰子ォレイン)を得た (IV13. 9、 収率 40%)  After dissolving 1 part of coconut oil of IV 8.1 in 4 parts of acetone, cooling to 4 ° C and allowing the crystals to crystallize, hold for 30 minutes, then separate under reduced pressure into a crystal part and a filtrate part. . A liquid fraction (Isogo olein) was obtained as a low melting point fraction of coconut oil by solvent removal from the filtrate part (IV13.9, yield 40%)
[0021] 製造例 3 [0021] Production Example 3
製造例 1で得たパーム核ダブルォレインを用いてソディウムメチラートによるランダム エステル交換を常法に従って実施した。  Using the palm kernel double olein obtained in Production Example 1, random transesterification with sodium methylate was carried out according to a conventional method.
[0022] 製造例 4 [0022] Production Example 4
中鎖脂肪酸トリグリセリド MCT (ココナード MT— N、花王 (株)製)と精製なたね油を 1 3: 87 (重量比)で混合し、常法に従ってこの混合油のランダムエステル交換を行なつ これらのパーム核ォレイン、パーム核ダブルォレイン、椰子ォレイン、パーム核ダブル ォレインランダムエステル交換油脂および製造例 4で得られたランダムエステル交換 油脂を常法により精製した。それらの脂肪酸組成およびトリグリセリド組成を表 1およ び 2に示した。表 1より、パーム核ォレイン、パーム核ダブルォレイン、椰子ォレイン、 パーム核ダブルォレインランダムエステル交換油脂および製造例 4で得られたランダ ムエステル交換油脂の SZUはそれぞれ 3. 42、 1. 99、 6. 75、 1. 99および 0. 25 であり、 C12ZUはそれぞれ 1. 96、 1. 04、 3. 41、 1. 04および 0であった。また表 2 より、パーム核ォレイン、パーム核ダブルォレイン、椰子ォレイン、パーム核ダブルォ レインランダムエステル交換油脂および製造例 4で得られたランダムエステル交換油 脂の C32〜36はそれぞれ 37. 7%、 26. 9%、 59. 8%、 18. 4%および 8. 1%であ り、 C42〜48はそれぞれ 30. 4%、 40. 6%、 14. 4%、 47. 7%および 36. 7%であ つた。ただし C32〜36 : ァシル基の炭素数合計が 32〜36個であるトリグリセリド、 C 42-48: ァシル基の炭素数合計が 42〜48個であるトリグリセリドである。 Medium chain fatty acid triglyceride MCT (Coconard MT—N, manufactured by Kao Corporation) and refined rapeseed oil are mixed at 1: 3: 87 (weight ratio), and random transesterification of this mixed oil is performed according to a conventional method. These palm kernel olein, palm kernel double olein, palm olein, palm kernel double olein random transesterified oil and fat, and the random transesterified oil obtained in Production Example 4 were purified by a conventional method. Their fatty acid composition and triglyceride composition are shown in Tables 1 and 2. From Table 1, SZU of palm kernel olein, palm kernel double olein, palm olein, palm kernel double olein random transesterified oil and fat and the random transesterified oil obtained in Production Example 4 are 3.42, 1.99 and 6. 75, 1.99 and 0.25, and C12ZU was 1.96, 1.04, 3.41, 1.04 and 0, respectively. In addition, from Table 2, C32 to 36 of palm kernel olein, palm kernel double olein, palm olein, palm kernel double olein random transesterified oil and the random transesterified oil obtained in Production Example 4 are 37.7% and 26. 9%, 59.8%, 18.4%, and 8.1%, and C42 to 48 are 30.4%, 40.6%, 14.4%, 47.7%, and 36.7%, respectively. It was. However, C32-36: Triglyceride in which the total carbon number of the acyl group is 32 to 36, C 42-48: Triglyceride in which the total carbon number of the acyl group is 42 to 48.
[0023] <表 1 > [0023] <Table 1>
Figure imgf000006_0001
Figure imgf000006_0001
[0024] 分析条件  [0024] Analysis conditions
硫酸触媒により各油脂試料の n—ブタノールとの反応にてブチルエステルを調製し、 以下の glc条件で分析した。得られたクロマトデータ (プチルエステルとしての重量% )の分子量換算によって、メチルエステルとしての重量%で表した。  Butyl esters were prepared by reaction of each oil sample with n-butanol using a sulfuric acid catalyst and analyzed under the following glc conditions. The obtained chromatogram data (% by weight as a ptyl ester) was expressed in terms of weight% as a methyl ester in terms of molecular weight.
glc分析条件  glc analysis conditions
試料:上記調製ブチルエステル 30 μ 1の 1mlへキサン溶液  Sample: 1 ml hexane solution of 30 μ 1 of the butyl ester prepared above
インジェクション量: 0. 5 ^ 1  Injection amount: 0.5 ^ 1
機器:島津製作所 (株)製 GC— 2010  Equipment: GC—2010, manufactured by Shimadzu Corporation
キヤビラリ一力ラム:信和化工 (株)製 ULBON HR— SS— 10 (0. 25mml. D. 50 m) カラム温度: 200°C、検出器 (FID)温度: 250°C First-class rams: Shinwa Kako Co., Ltd. ULBON HR— SS— 10 (0.25 mml. D. 50 m) Column temperature: 200 ° C, detector (FID) temperature: 250 ° C
[0025] <表 2> [0025] <Table 2>
トリグリセリド(C32〜C36、及び C42〜48)の含有量  Content of triglycerides (C32 to C36 and C42 to 48)
Figure imgf000007_0001
Figure imgf000007_0001
[0026] 分析条件 [0026] Analysis conditions
各油脂試料をそのまま、以下の glc条件で分析した。  Each oil sample was directly analyzed under the following glc conditions.
glc分析条件  glc analysis conditions
試料濃度:油脂 50 1の 1. 5mlへキサン溶液  Sample concentration: 1.5 ml hexane solution of fat 50 1
インジェクション量:1 1  Injection volume: 1 1
機器:ヒューレットパッカード社製 ΗΡ6850シリーズ GCシステム  Equipment: ヒ ュ ー 6850 Series GC system manufactured by Hewlett-Packard Company
キヤピラリーカラム: Frontier Lab製 UA15W 0. 15F (0. 5mml. D. 15m) カラム温度: 220°Cから毎分 12°Cで 350°Cまで昇温  Capillary column: Frontier Lab UA15W 0.15F (0.5 mml. D. 15m) Column temperature: 220 ° C to 12 ° C / min up to 350 ° C
検出器 (FID)温度: 350°C  Detector (FID) temperature: 350 ° C
[0027] <実施例 1 > <Example 1>
マウスでの消化吸収試験(1)  Digestion and absorption test in mice (1)
パーム核ォレイン、製造例 1〜3で得られたパーム核ダブルォレイン、椰子ォレインお よびパーム核ダブルォレインランダムエステル交換油脂の各精製油を使用して 8週 間のマウスでの消化吸収試験を行った。使用したマウスは C57BLZ6Jであり、 7週 齢から 1週間予備飼育後、 AIN— 93G組成を一部改良した表 3の配合飼料食餌組 成にて大豆油群をコントロールにして各群 8匹で 8週間飼育し、体重変化'飼料効率 •体脂肪率の測定を行った。体脂肪率の測定は、実験マウス専用エックス線骨密度 測定装置、 PIXImus2 (GE Medical Systems)を使用した。  Digestion and absorption tests were conducted in mice for 8 weeks using each refined oil of palm kernel olein, palm kernel double olein, palm olein and palm kernel double olein random transesterified oil obtained in Production Examples 1 to 3. It was. The mouse used was C57BLZ6J. After pre-breeding from 7 weeks of age to 1 week, 8 mice in each group were controlled with the soybean oil group in the mixed feed diet composition shown in Table 3 with a partial improvement in the AIN-93G composition. Breeding for weeks, body weight change 'feed efficiency • Body fat percentage was measured. The body fat percentage was measured using a PIXImus2 (GE Medical Systems), an X-ray bone density measuring device dedicated to experimental mice.
[0028] <表 3 > 食餌組成 (wt%) [0028] <Table 3> Diet composition (wt%)
Figure imgf000008_0001
Figure imgf000008_0001
[0029] マウスでの 56日間の消化吸収試験の結果を表 4に示した。パーム核ダブルォレイン を使用した群ではコントロールとしての大豆油群に対して、体重増加で約 12%の抑 制が認められ、また体脂肪率では約 17%の抑制が観られ、脂肪の過剰摂取による 肥満防止油脂としてパーム核ダブルォレインが効果的であることが示唆された。 [0029] Table 4 shows the results of a 56-day digestion and absorption test in mice. In the group using palm kernel double olein, about 12% suppression of body weight gain was observed compared to the soybean oil group as a control, and about 17% suppression was observed in body fat percentage, which was caused by excessive intake of fat. It was suggested that palm kernel double olein is effective as an anti-obesity oil.
[0030] <表 4 >  [0030] <Table 4>
飼育結果  Rearing result
Figure imgf000008_0002
Figure imgf000008_0002
これとは逆にパーム核ォレインを使用した群においてはコントロールとしての大豆油 群に対して、体重増加で約 18%の増加が認められ、また体脂肪率でも約 9%の増加 が観られた。また椰子ォレインを使用した群においては大豆油群に対して、体重増 加ではほとんど変化が認められず、体脂肪率では約 6%の増加が観られた。一方、 パーム核ダブルォレインのランダムエステル交換油脂を使用した群の場合は、体重 増加および体脂肪率は大豆油群に対してそれぞれ約 8%および約 6%の抑制にとど まり、パーム核ダブルォレインほどの肥満防止効果を示さな力つた。これらの結果を 表 5に纏めた。 On the other hand, in the group using palm kernel olein, an increase of about 18% was observed in weight gain and an increase of about 9% in body fat percentage as compared with the soybean oil group as a control. . In the group using coconut olein, there was almost no change in weight gain compared to the soybean oil group, and an increase of about 6% in body fat percentage was observed. on the other hand, In the group using palm kernel doubleolein random transesterified oil and fat, body weight gain and body fat percentage were only about 8% and about 6% lower than the soybean oil group, respectively, and obesity as much as palm kernel doubleolein. It did not show a preventive effect. These results are summarized in Table 5.
[0032] <表 5> [0032] <Table 5>
各試験油脂群の大豆油群に対しての効果の比較  Comparison of the effect of each test oil group on soybean oil group
Figure imgf000009_0001
Figure imgf000009_0001
[0033] 更に、 56日間の飼育後に対照群および各試験群のマウスの血中脂質および解剖後 の肝臓脂質のトリグリセリド量を定量分析し、その結果を表 6に示した。各試験油脂群 の大豆油群に対しての増減率として効果をまとめた表 7に示されて 、るように、パーム 核ダブルォレインのみが血中および肝臓脂質中のトリグリセリド量を、コントロールとし ての大豆油群に対して大きく抑制が見られた。 [0033] Further, after 56 days of breeding, the amounts of triglycerides in blood lipids and liver lipids after dissection in the control group and each test group were quantitatively analyzed, and the results are shown in Table 6. As shown in Table 7, which summarizes the effect of each test fat group on the rate of increase / decrease relative to the soybean oil group, only palm kernel doubleolein controls the amount of triglycerides in blood and liver lipids as a control. Significant suppression was seen for the soybean oil group.
[0034] <表 6>  [0034] <Table 6>
血中および肝臓脂質中のトリグリセリド (TG)量 パ一ム核ォレイン パーム核ダブル 大豆油群  Triglyceride (TG) levels in blood and liver lipids Palm kernel olein Palm kernel double Soybean oil group
使用群 ォレイン使用群 血中 TG(mgZdL) 103. 7±7. 6 95. 1 ±5. 8 90. 9±5. 1 肝 TG(mg/ gLiver) 85. 2±8. 1 85. 3±7.8 56.4±7. 5  Use group Olean use group Blood TG (mgZdL) 103.7 7 ± 7. 6 95. 1 ± 5. 8 90. 9 ± 5. 1 Liver TG (mg / gLiver) 85. 2 ± 8. 1 85. 3 ± 7.8 56.4 ± 7.5
椰子ォレイン パーム核ダブルォレイン  Zhuang Olaiin Palm nuclear double olein
使用群 ランダムエステル交換油脂使用群 血中 TG(mgZdL) 99. 8±7. 2 97. 8±4.4  Use group Random transesterified oil use group Blood TG (mgZdL) 99. 8 ± 7. 2 97. 8 ± 4.4
fl†TG(mg/gLiver 82. 2±7. 3 80. 4±9. 1 [0035] <表 7 > fl † TG (mg / gLiver 82. 2 ± 7. 3 80. 4 ± 9.1 [0035] <Table 7>
各試験油脂群の大豆油群に対しての増減率  Increase / decrease rate of each test fat group with respect to soybean oil group
Figure imgf000010_0001
Figure imgf000010_0001
[0036] <実施例 2 >  <Example 2>
マウスでの消化吸収試験(2)  Digestion and absorption test in mice (2)
製造例 1で得られたパーム核ダブルォレインの精製油および製造例 4で得られた M CTとなたね油のランダムエステル交換油脂を使用して大豆油群をコントロールにし て、実施例 1と同じ条件で飼育し、体重変化,飼料効率,体脂肪率の測定を行った。 ただし各群 6匹とし飼育期間は 111日間にて実施した。体脂肪率の測定については 、飼育前、飼育途中(56日間飼育)および飼育終了時(111日)の時点で実施した。 更に、 111日間の飼育後に対照群および各試験群のマウスの血中脂質および解剖 後の肝臓脂質のトリグリセリド量を定量分析した結果を表 8、表 10に示す。  Breeding under the same conditions as in Example 1, using the refined oil of palm kernel double olein obtained in Production Example 1 and the random transesterified fat of MCT obtained in Production Example 4 as a control and soybean oil group Then, changes in body weight, feed efficiency, and body fat percentage were measured. However, each group had 6 animals and the breeding period was 111 days. The body fat percentage was measured before breeding, during breeding (bred for 56 days) and at the end of breeding (111 days). Further, Tables 8 and 10 show the results of quantitative analysis of blood lipids and post-dissection liver lipid triglyceride levels in mice of the control group and each test group after 111 days of breeding.
[0037] <表 8 > [0037] <Table 8>
飼育結果  Rearing result
Figure imgf000010_0002
Figure imgf000010_0002
[0038] <表 9 >  [0038] <Table 9>
血中および肝臓脂質中のトリグリセリド (TG)量 パーム核ダブル 製造例 4の油脂 大豆油群 Triglyceride (TG) levels in blood and liver lipids Palm kernel double Oil of production example 4 Soybean oil group
ォレイン使用群 使用群 血中 TG(mgZdL) 103. 3±9. 7 95. 8±5. 9 124.0±8.0 肝 TG(mgZgLiver) 180±43 157±29 138±12  Olein use group Use group Blood TG (mgZdL) 103.3 3 ± 9. 7 95. 8 ± 5. 9 124.0 ± 8.0 Liver TG (mgZgLiver) 180 ± 43 157 ± 29 138 ± 12
[0039] 各試験油脂群の大豆油群に対しての増減率として効果をまとめた表 9および表 11に 示されているように、パーム核ダブルォレインは同等の飼料効率にて、製造例 4で得 られた MCT、なたね油混合油のランダムエステル交換油脂と比較して大豆油群に対 してより大きな体重増加抑制および体脂肪蓄積抑制ならびに血液中の中性脂質低 減効果が認められた。 [0039] As shown in Table 9 and Table 11, which summarizes the effect as the rate of change of each test fat group with respect to the soybean oil group, palm kernel double olein has the same feed efficiency as in Production Example 4. Compared with the MCT and rapeseed oil random transesterified fats and oils obtained, the soybean oil group showed a greater suppression of body weight gain and body fat accumulation and a reduction in neutral lipids in the blood.
[0040] <表 10>  [0040] <Table 10>
各試験油脂群の大豆油群に対しての効果の比較  Comparison of the effect of each test oil group on soybean oil group
Figure imgf000011_0001
Figure imgf000011_0001
[0041] <表 11>  [0041] <Table 11>
各試験油脂群の大豆油群に対しての増減率  Increase / decrease rate of each test fat group with respect to soybean oil group
Figure imgf000011_0002
Figure imgf000011_0002
[0042] 最後に表 12に大豆油を対照にして本実施結果を示すとおり、構成する脂肪酸の組 成において SZUが 0.6〜2.5であり、かつ C12ZUが 0.4〜1.5であり、かつ構成 するトリグリセリドの組成においてァシル基の炭素数合計が 32〜36であるトリグリセリ ドが全体の 30%未満であり、かつァシル基の炭素数合計力 2〜48であるトリグリセリ ドを全体の 35%以上を含有するものは、体重増加抑制および体脂肪蓄積抑制用な らびに血中および肝臓脂質中の中性脂質を低減させることができる。 [0043] <表 12 > [0042] Finally, as shown in Table 12, the results of this experiment with soybean oil as a control are shown. In the composition of fatty acids, SZU is 0.6 to 2.5, and C12ZU is 0.4 to 1.5. Containing less than 30% of the total triglycerides having a total of 32 to 36 carbon atoms in the composition and containing 35% or more of the total triglycerides having a total carbon number of 2 to 48 for the acyl groups. Can reduce body weight gain, body fat accumulation, and neutral lipids in blood and liver lipids. [0043] <Table 12>
Figure imgf000012_0001
Figure imgf000012_0001
[0044] 上記、表 12の各種抑制低減効果についての記号説明  [0044] Explanation of symbols for various suppression reduction effects in Table 12 above
X · · '対照としての大豆群に比べて劣る。  X · 'Inferior to the soybean group as a control.
△ · · '対照としての大豆群と比べ僅かしか低減効果がない。  △ · · 'There is little reduction effect compared to the soybean group as a control.
〇 · · '対照としての大豆群と比べ低減効果が明らかである。  ○ · · 'The reduction effect is clear compared with the soybean group as a control.
◎ · · ·対照としての大豆群と比べ低減効果が著しい。  ◎ · · · Significant reduction effect compared to soybean group as control.
体重増加抑制、体脂肪蓄積抑制、血液中性脂質の低減および肝臓中性脂質の低 減など、これら全ての抑制低減効果を同時に著しく示している油脂組成物は、本発 明で規定した油脂組成を有する場合のみである。  The oil / fat composition that has shown all of these effects of reducing body weight gain, body fat accumulation, blood neutral lipid and liver neutral lipid, etc. It is only when it has.
[0045] <実施例 3 > <Example 3>
マウスでの高脂肪食長期摂食試験 (3)  High fat diet long-term feeding test in mice (3)
パーム核ォレイン、製造例 1で得られたパーム核ダブルォレインの各精製油を使用し て 140日間のマウスでの高脂肪食長期摂食試験を行った。使用したマウスは C57B L/6Jであり、 6週齢から 1週間予備飼育後、 AIN— 93G組成を一部改良した表 13 の配合飼料食餌組成にて大豆油群をコントロールにして各群 16匹で 140日間飼育 し、体重変化'各臓器重量'血液性状の測定を行った。  Using each refined oil of palm kernel olein and palm kernel double olein obtained in Production Example 1, a high-fat diet long-term feeding test in mice for 140 days was conducted. The mouse used was C57B L / 6J. After pre-breeding from 6 weeks of age to 1 week, AIN-93G composition was partially modified. The animals were reared for 140 days, and changes in body weight “weight of each organ” were measured for blood properties.
[0046] <表 13 > [0046] <Table 13>
食餌組成 (wt%) 組成 大豆油群 試験油脂使用群 大豆油 30. 0 3. 0 試験油脂 ― 27. 0Diet composition (wt%) Composition Soybean oil group Test oil and fat use group Soybean oil 30. 0 3. 0 Test oil and fat-27.0
Casein 20. 0 20. 0Casein 20. 0 20. 0
Sucrose 1 3. 2 1 3. 2 β— corn starch 1 3. 75 1 3. 75 Sucrose 1 3. 2 1 3. 2 β— corn starch 1 3. 75 1 3. 75
Οί— corn stsrch 1 3. 2 1 3. 2  Οί— corn stsrch 1 3. 2 1 3. 2
L— Cystine 0. 3 0. 3 cellulose powder 5. 0 5. 0  L— Cystine 0. 3 0. 3 cellulose powder 5. 0 5. 0
Min. mix (AIN - 93G) 3. 5 3. 5  Min.mix (AIN-93G) 3.5 5 3.5
Vit. mix (AIN - 93G) 1 . 0 1 . 0  Vit.mix (AIN-93G) 1. 0 1. 0
Choline bitartrate 0. 25 0. 25  Choline bitartrate 0. 25 0. 25
[0047] マウスでの 140日間の高脂肪食長期摂食試験の結果を表 14に示した。パーム核ダ ブルォレインを使用した群ではコントロールとしての大豆油群に対して、体重増加で 約 4. 2%の抑制が認められた。 [0047] Table 14 shows the results of a 140-day high-fat diet long-term feeding test in mice. In the group using palm kernel double violet, about 4.2% reduction in body weight was observed compared to the soybean oil group as a control.
[0048] <表 14 >  [0048] <Table 14>
飼育結果  Rearing result
Figure imgf000013_0001
Figure imgf000013_0001
[0049] 更に、 140日間の飼育後に対照群およびパーム核ダブルォレイン群のマウスの血中 脂質量を測定し、その結果を表 15に示した。パーム核ダブルォレイン群の大豆油群 に対しての増減率として効果をまとめた表 15に示されて 、るように、パーム核ダブル ォレインが血中トリグリセリド量を、コントロールとしての大豆油群に対して大きく抑制 が見られた。よって、高脂肪食条件においてもパーム核ダブルォレイン群では体重 抑制および血中脂質抑制効果を有することが示された。  [0049] Furthermore, blood lipid levels were measured in mice of the control group and palm kernel double aurein group after 140 days of breeding, and the results are shown in Table 15. As shown in Table 15 which summarizes the effect as the rate of increase / decrease of the palm kernel double olein group with respect to the soybean oil group, the palm kernel double olein has the blood triglyceride content as compared with the soybean oil group as a control. Significant suppression was seen. Therefore, it was shown that the palm kernel double olein group has an effect of suppressing body weight and blood lipid even under high fat diet conditions.
[0050] <表 15 >  [0050] <Table 15>
血中脂質量と大豆油群に対するパーム核ダブルォレイン使用群の増減率 (%)
Figure imgf000014_0001
Increase / decrease rate of palm kernel doubleolein group relative to blood lipid level and soybean oil group (%)
Figure imgf000014_0001

Claims

請求の範囲 The scope of the claims
[1] 構成する脂肪酸の組成において SZUが 0. 6〜2. 5、 C12ZUが 0. 4〜1. 5であり 、かつ構成するトリグリセリドの組成においてァシル基の炭素数合計が 32〜36個で あるトリグリセリドが全体の 30%未満、ァシル基の炭素数合計が 42〜48個であるトリ グリセリドを全体の 35%以上含有する脂質代謝改善用油脂組成物。ただし S:メチル エステルとしての重量%で表した飽和脂肪酸含量の合計、 U:メチルエステルとして の重量%で表した不飽和脂肪酸含量の合計。  [1] The composition of fatty acids is SZU of 0.6 to 2.5, C12ZU is 0.4 to 1.5, and the composition of triglycerides is composed of 32 to 36 carbon atoms in the asil group. An oil / fat composition for improving lipid metabolism, comprising less than 30% of a triglyceride and 35% or more of a triglyceride having a total of 42 to 48 carbon atoms in the acyl group. Where S: total saturated fatty acid content expressed as weight percent as methyl ester, U: total unsaturated fatty acid content expressed as weight percent as methyl ester.
[2] パーム核油を分別することによって得られる請求項 1記載の脂質代謝改善用油脂組 成物。  [2] The fat composition for lipid metabolism improvement according to claim 1, obtained by fractionating palm kernel oil.
[3] パーム核油を複数回分別することによって得られる請求項 1、 2記載の脂質代謝改善 用油脂組成物。  [3] The fat and oil composition for improving lipid metabolism according to claim 1 or 2, obtained by fractionating palm kernel oil a plurality of times.
[4] パーム核油を乾式分別することによって得られる請求項 1、 2記載の脂質代謝改善用 油脂組成物。  [4] The fat composition for improving lipid metabolism according to claim 1 or 2, obtained by dry fractionating palm kernel oil.
PCT/JP2007/051043 2006-01-30 2007-01-24 Fat composition for ameliorating lipid metabolism WO2007086397A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007555962A JPWO2007086397A1 (en) 2006-01-30 2007-01-24 Oil composition for improving lipid metabolism

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006-020038 2006-01-30
JP2006020038 2006-01-30

Publications (1)

Publication Number Publication Date
WO2007086397A1 true WO2007086397A1 (en) 2007-08-02

Family

ID=38309186

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/051043 WO2007086397A1 (en) 2006-01-30 2007-01-24 Fat composition for ameliorating lipid metabolism

Country Status (2)

Country Link
JP (1) JPWO2007086397A1 (en)
WO (1) WO2007086397A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016002015A (en) * 2014-06-16 2016-01-12 日清オイリオグループ株式会社 chocolate
JP2020068674A (en) * 2018-10-29 2020-05-07 株式会社Adeka Complex bread dough

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60241853A (en) * 1984-05-16 1985-11-30 Fuji Oil Co Ltd Preparation of chocolate for ice coating
JPH02700A (en) * 1987-05-30 1990-01-05 Fuji Oil Co Ltd Fatty oil, and fatty oil-containing food prepared by using same
JP2004123839A (en) * 2002-09-30 2004-04-22 Fuji Oil Co Ltd Dry fractionation method of fats and oils

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60241853A (en) * 1984-05-16 1985-11-30 Fuji Oil Co Ltd Preparation of chocolate for ice coating
JPH02700A (en) * 1987-05-30 1990-01-05 Fuji Oil Co Ltd Fatty oil, and fatty oil-containing food prepared by using same
JP2004123839A (en) * 2002-09-30 2004-04-22 Fuji Oil Co Ltd Dry fractionation method of fats and oils

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016002015A (en) * 2014-06-16 2016-01-12 日清オイリオグループ株式会社 chocolate
JP2020068674A (en) * 2018-10-29 2020-05-07 株式会社Adeka Complex bread dough

Also Published As

Publication number Publication date
JPWO2007086397A1 (en) 2009-06-18

Similar Documents

Publication Publication Date Title
EP1307108B1 (en) Oil/fat composition
US20070141220A1 (en) Composition enriched in diglyceride with conjugated linoleic acid
WO2004018598A1 (en) Fat composition
WO2007122801A1 (en) Gip secretion inhibitor
JP2008069184A (en) Oil-and-fat composition
JP5099808B2 (en) Composition for improving lipid metabolism
US20100210723A1 (en) Lipase inhibitor
WO2005079591A1 (en) Fats and oils composition containing diglycerid, and margarine, fried oil and food containing the composition
JP3597437B2 (en) Edible fats and oils with blood lipid improving function
JP3482253B2 (en) Cooking fats and oils
WO2007086397A1 (en) Fat composition for ameliorating lipid metabolism
JP7023732B2 (en) Treatment or prevention of liver disease with inflammation
JP4634065B2 (en) Adiponectin reduction inhibitor
JP4268473B2 (en) Oil composition
WO2007129439A1 (en) Inhibitor of increase in postprandial blood insulin level
KR100684641B1 (en) Oil composition, food and health food containing the same
JP2008067677A (en) Edible fat-and-oil composition having antiobese effect and beverage and feed each using the same
JP5479696B2 (en) In vivo plasmalogen increasing agent
JP4719715B2 (en) Oil composition
JP5211529B2 (en) Liver function improving agent
JP2010241832A (en) Adiponectin decrease inhibitor
JP2006151875A (en) Lipase inhibitor
JPWO2004022050A1 (en) Lipid metabolism regulator and food and drink
JP3135370B2 (en) Low calorie fat
JP2003265104A (en) Oil-and-fat composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2007555962

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07707294

Country of ref document: EP

Kind code of ref document: A1